Biocompatible Gadolinium-free contrast agents for molecular targeted MR imaging [ 1/1/2021 - 6/30/2026 ]

Research Grant

Brief description Building on the biomedical engineering of USPIOs, this project expects to generate new probing tools for non-invasive molecular imaging and affect subsequent clinical imaging through earlier and more accurate diagnosis of diseases. The project will allow the delivery of new knowledge in the emerging field of nanomedicine with high clinical translation potentials.

Funding Amount $645,205

Funding Scheme Investigator Grants

Chief Investigator Dr Ruirui Qiao

Notes Emerging Leadership 1